Production (Stage)
GenSight Biologics S.A.
GSGTF
$0.24
-$0.08-25.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.15M | -18.48M | -21.76M | -25.12M | -28.36M |
| Total Depreciation and Amortization | 1.15M | 1.71M | 2.27M | 2.32M | 2.36M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -937.50K | 57.90K | 1.06M | -1.15M | -3.32M |
| Change in Net Operating Assets | 946.50K | 1.15M | 1.34M | 2.00M | 2.66M |
| Cash from Operations | -13.99M | -15.56M | -17.09M | -21.96M | -26.66M |
| Capital Expenditure | -1.00K | -6.40K | -11.80K | -11.30K | -10.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.50K | 52.30K | 85.50K | 161.80K | 236.70K |
| Cash from Investing | 18.40K | 45.80K | 73.60K | 150.40K | 225.90K |
| Total Debt Issued | -- | 3.09M | 6.18M | 10.18M | 14.18M |
| Total Debt Repaid | -2.90M | -1.80M | -698.00K | -1.29M | -1.87M |
| Issuance of Common Stock | 14.00M | 14.27M | 14.54M | 9.25M | 3.96M |
| Repurchase of Common Stock | -27.00K | -74.00K | -121.00K | -110.00K | -99.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.47M | 2.07M | 1.68M | 687.00K | -308.00K |
| Cash from Financing | 14.64M | 18.98M | 23.35M | 20.31M | 17.15M |
| Foreign Exchange rate Adjustments | -317.20K | -125.50K | 71.50K | 100.30K | 128.70K |
| Miscellaneous Cash Flow Adjustments | -- | -500.00 | -1.00K | -500.00 | 0.00 |
| Net Change in Cash | 347.90K | 3.33M | 6.40M | -1.41M | -9.16M |